Artificial intelligence tool to improve heart failure care
Science Daily - Heart Disease
MAY 14, 2024
The powerful new AI tool can predict heart failure outcomes in specific patients, helping doctors improve care.
Science Daily - Heart Disease
MAY 14, 2024
The powerful new AI tool can predict heart failure outcomes in specific patients, helping doctors improve care.
DAIC
MAY 14, 2024
Getty Images milla1cf Tue, 05/14/2024 - 13:00 May 14, 2024 — One of the most common genetic heart diseases worldwide, hypertrophic cardiomyopathy (HCM) causes the walls of the left ventricle to become thick and stiff. In about 70 percent of cases, patients with HCM experience obstruction to blood flow, which increases pressures in the heart and can lead to chest pain, shortness of breath and reduced exercise capacity.
HCPLive
MAY 14, 2024
A study showed tildrakizumab treated difficult-to-treat psoriasis areas in patients who failed anti-IL17 treatment.
DAIC
MAY 14, 2024
milla1cf Tue, 05/14/2024 - 12:53 May 14, 2024 — GE HealthCare , a leading global medical technology, pharmaceutical diagnostics and digital solutions innovator, and Medis Medical Imaging , a leading cardiac imaging software company, announced their collaboration aimed at helping advance precision care in the diagnosis and treatment of coronary artery disease ( CAD ).
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
HCPLive
MAY 14, 2024
Patients with hidradenitis suppurativa had the greatest risk of developing various CVS, with heart failure being the most common one.
American Heart News - Heart News
MAY 14, 2024
Guideline Highlights: The new joint guideline from the American Heart Association and the American College of Cardiology provides recommendations to guide clinicians in the treatment of patients with lower extremity peripheral artery disease (PAD) and.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
DAIC
MAY 14, 2024
UVA Health's Karen Johnston, MD, the SHINE trial leader, was pleased to see the new insights into best practices for stroke care. “These data from the SHINE trial continue to inform the national stroke community about potential approaches to treating hyperglycemic stroke patients to assure better outcomes,” she said. Dan Addison | UVA Communications milla1cf Tue, 05/14/2024 - 12:57 May 14, 2024 — An ambitious, nationwide clinical trial led by UVA Health ’s Karen Johnston , MD, has provided docto
Cardiovascular Diabetology
MAY 14, 2024
Diabetic heart disease (DHD) is a serious complication in patients with diabetes. Despite numerous studies on the pathogenic mechanisms and therapeutic targets of DHD, effective means of prevention and treatme.
JAMA Cardiology
MAY 14, 2024
This cohort study examines data for men and women 40 years and older to determine the association between high-volume leisure-time aerobic physical activity and the progression of coronary artery calcium over time.
American Heart News - Heart News
MAY 14, 2024
DALLAS, May 14, 2024 — Living with a chronic medical condition after surviving a heart attack or stroke may come with additional health and personal care needs. Often survivors must rely on a family member or close friend to help. However, there’s a.
Becker's Hospital Review - Cardiology
MAY 14, 2024
UPMC Harrisburg pioneers new transcatheter aortic valve replacement system, providing improved lifetime management for patients with aortic valve stenosis.
JAMA Cardiology
MAY 14, 2024
This cohort study examines whether there is an association between osteosarcopenia and adverse outcomes, such as increased risk of mortality, in older adults following transcatheter aortic valve replacement (TAVR).
Nature Reviews - Cardiology
MAY 14, 2024
Nature Reviews Cardiology, Published online: 15 May 2024; doi:10.1038/s41569-024-01037-7 In this Review, Adkar and Leeper describe the mechanisms of programmed cell death and efferocytosis, discuss how efferocytosis becomes impaired in atherosclerosis and other cardiometabolic diseases, and suggest potential strategies to target these pathways for the treatment of atherosclerotic cardiovascular disease.
NEJM Journal Watch - Cardiology
MAY 14, 2024
Within 30 days of antihypertensive medication initiation, the rate of fracture was more than twice as high in initiators than in noninitiators.
HCPLive
MAY 14, 2024
The CRL for the sBLA cites a lack of sufficient data to support the full evaluation of the effectiveness and safety of a 4-dose regimen in this patient population.
American Heart News - Heart News
MAY 14, 2024
Aspectos destacados de la guía: La nueva guía conjunta de la American Heart Association (la Asociación Americana del Corazón) y el American College of Cardiology ofrece recomendaciones para guiar a los médicos en el tratamiento de pacientes con.
HCPLive
MAY 14, 2024
Age and sickle cell disease genotype predicted individuals with sickle cell retinopathy at risk for proliferative disease.
Becker's Hospital Review - Cardiology
MAY 14, 2024
Jupiter (Fla.) Medical Center established the Elliot Family Center for Cardiac Electrophysiology thanks to a $10 million donation, CBS12 reported May 13.
HCPLive
MAY 14, 2024
The FDA has extended the review period for palopegteriparatide in treatment of hyperparathyroidism in adult patients by 3 months to August 14, 2024.
American Heart News - Heart News
MAY 14, 2024
DALLAS, 14 de mayo de 2024 — Vivir con una afección médica crónica luego de sobrevivir a un ataque cardíaco o derrame cerebral puede acarrear muchas otras necesidades de cuidado personal y de salud, y con frecuencia los supervivientes deben recurrir a la.
HCPLive
MAY 14, 2024
Study results highlight the role of HCV and alcohol use in the growing global disease burden posed by cirrhosis, which is projected to increase over the next 20 years.
Cardiovascular Diabetology
MAY 14, 2024
Although the TyG index is a reliable predictor of insulin resistance (IR) and cardiovascular disease, its effectiveness in predicting major adverse cardiac events in hospitalized acute coronary syndrome (ACS).
HCPLive
MAY 14, 2024
A systematic review and meta-analysis of 51 studies suggests elevated Lp(a) can help predict risk of premature atherosclerotic cardiovascular disease.
Frontiers in Cardiovascular Medicine
MAY 14, 2024
Vascular endothelial cells play an important role in regulating peripheral circulation by modulating arterial tone in the microvasculature. Elevated intracellular Ca2+ levels are required in endothelial cells to induce smooth muscle relaxation via endothelium-dependent mechanisms such as nitric oxide production, prostacyclin, and endothelial cell hyperpolarization.
HCPLive
MAY 14, 2024
These results may support clinical decision-making for psoriasis and nail psoriasis management and may allow future real-world studies to further understand the nature of this skin disease.
Frontiers in Cardiovascular Medicine
MAY 14, 2024
BackgroundTriglyceride-glucose (TyG) index and hypertension were well-established risk factors for stroke. And TyG index was associated with hypertension. However, no prior study has investigated the interactive effects of the TyG index and hypertension on stroke. This study examined whether hypertension mediates associations of TyG index with incident stroke and the extent of interaction or joint relations of TyG index and hypertension with stroke in middle-aged and older Chinese adults.Methods
HCPLive
MAY 14, 2024
Within one month of treatment, anti-VEGF therapy improves anatomic and visual outcomes among eyes with stage 3 and 4 proliferative sickle cell retinopathy.
Med Page Today
MAY 14, 2024
(MedPage Today) -- PARIS -- Using a structured series of tests together, operators greatly improved the diagnostic accuracy of invasive coronary angiography (ICA) for people with chronic coronary syndrome (CCS), the prospective AID-ANGIO study.
HCPLive
MAY 14, 2024
Further analyses into the 2-year PROTECT trial further support the longevity of benefit with sparsentan in patients with IgAN.
Med Page Today
MAY 14, 2024
(MedPage Today) -- PARIS -- For patients with severe aortic stenosis (AS) and concomitant obstructive coronary artery disease (CAD), a percutaneous combined intervention worked surprisingly well relative to surgery, the TCW randomized trial found.
HCPLive
MAY 14, 2024
This interview featured a discussion of Alexis’s team’s findings on the importance of treating patients with skin of color and acne-induced post-inflammatory hyperpigmentation.
Cardiology Update
MAY 14, 2024
Intravascular imaging (IVI), such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), play a crucial role in assessing lesion characteristics and optimizing stent placement during percutaneous coronary intervention (PCI). Studies have consistently shown that procedural optimization guided by IVUS leads to better clinical outcomes compared to angiography-guided PCI alone.
HCPLive
MAY 14, 2024
Data presented at NKF Spring Clinical Meeting suggest events including myocardial infarction and stroke are more prevalent among patients with lupus in North America.
NEJM Journal Watch - Cardiology
MAY 14, 2024
A clinical trial in China suggests better outcomes with long-term clopidogrel monotherapy than DAPT.
HCPLive
MAY 14, 2024
Transmasculine patients undergoing GAHT may experience adverse lipid profile changes, unlike transfeminine counterparts, which investigators say is cause for closer monitoring.
Hypertension Journal
MAY 14, 2024
Hypertension, Volume 81, Issue 6 , Page 1254-1256, June 1, 2024.
Let's personalize your content